Date/Time
Date(s) - 04/11/2022 - 04/15/2022
All Day
Categories
Join FSR on Inspire from Monday, April 11th through Friday, April 15th.
Every year, FSR hosts a week-long online educational opportunity for patients to have their questions answered by a leading sarcoidosis expert in the field. Each day the experts will be answering your general sarcoidosis questions lead by the pulmonary team from The University of Texas Health.
This series will take place on Inspire, an online vital health community where millions of patients and caregivers can share information and provide support in a private, anonymous environment. Sign up for a free account and become part of our sarcoidosis community on Inspire today.
About the experts:
Rahat Hussain, MD
Dr. Hussain has been practicing at UT Health Science Center in Houston TX since 2012. He is a Pulmonary Critical Care and Lung Transplant Physician at Memorial Hermann Hospital at the Texas Medical Center which is the largest medical center in the world. Dr. Hussain is the Medical Director of the Sarcoidosis clinic at UT Health Science Center. He is also the Medical Director of the Heart and Lung Transplant Intermediate unit at Memorial Hermann Hospital and is responsible for quality and patient care outcomes. His practice includes taking care of patients in the ICU with Severe Respiratory failure, Severe Heart failure, and Lung Transplant patient’s management. Dr. Hussain’s outpatient clinic is focused on Sarcoidosis, COPD, Post-Transplant Pulmonary complications, Pre and Post Lung Transplant care, Pulmonary Fibrosis.
Dr. Hussain is a graduate of Dow Medical College, Karachi, Pakistan. After coming to United States for higher education and training he was involved in research at Detroit Medical Center, Wayne State University where he studied Neurocritical Care patients and Intracranial Hemorrhage. In addition, Dr. Hussain also did research with cardiac arrest patients and hypothermia. He was also involved with research at Baylor College of Medicine at the VA Hospital in Houston, where he managed to work with leaders in the Infectious disease Department.
He completed his Internal Medicine Training at UT-RAHC and joined fellowship in Pulmonary Critical Care Medicine at Baylor College of Medicine. During his training he also completed a Lung Transplant Fellowship at Baylor College of Medicine.
Pascal L. Kingah, MD, MPH
Dr. Kingah is an Assistant Professor of Medicine in the Department of Internal Medicine, Divisions of Critical Care and Pulmonary Medicine, at McGovern Medical School at The University of Texas Health Science Center at Houston. He is an active member of the American College of Chest Physicians. He is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine.
Dr. Kingah seeks to improve current asthma management and institute smoking cessation strategies. His special clinical interests include interstitial lung disease, specifically sarcoidosis and pulmonary fibrosis. He has contributed to several publications in which he was first author.
He is currently the medical director of intensive care at Memorial Hermann Cypress. He is also chair of Pharmacy and Therapeutics committee for Memorial Hermann Cypress. He has worked on scoring systems in the ICU that helped predict mortality in patients with cancer admitted to the ICU as revealed in his most recent publications. His other clinical interests include interstitial lung disease, specifically sarcoidosis and optimizing care of patients with sepsis. On his off days he likes fishing, hunting and swimming. He also loves soccer and still finds time to play. A former Detroit Tigers fan now an Astros fan.
Gautam Sikka, MD
Sr. Sikka is an assistant professor in medicine at UT health Science Houston and has completed his training in fields of internal medicine, critical care medicine and pulmonary medicine. While perusing his pulmonary and critical care training at Johns Hopkins Medicine in Baltimore-Maryland, Dr. Sikka spent additional time learning about pathophysiology of Sarcoidosis and applied my training in patient care at the Johns Hopkins Sarcoidosis Clinics.
After completing his training in 2021, he joined as faculty at the department of Pulmonary, Critical Care and Sleep medicine at University of Texas Health Science Center at Houston with a focus to be part of the Clinics of Sarcoidosis and build a multi-disciplinary team around the patients suffering from sarcoidosis.
Dr. Sikka’s research interests include, studying pulmonary diseases, especially the role of opsin biology in pulmonary vascular diseases, such as pulmonary hypertension (PH), a disease with unacceptably high mortality and morbidity. PH which is seen in some patients with sarcoidosis, is characterized by impaired pulmonary vascular dilation and dysregulation of cell death and turnover, leading to extreme vascular remodeling.
Sponsored by:
